FOCUS ON SIMVASTATIN - A POTENT HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA

被引:0
|
作者
QUERCIA, RA
机构
来源
HOSPITAL FORMULARY | 1989年 / 24卷 / 10期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:559 / &
相关论文
共 50 条
  • [1] FOCUS ON PRAVASTATIN - AN HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
    BROISMAN, L
    ENGSTER, P
    CHOW, MSS
    HOSPITAL FORMULARY, 1991, 26 (07): : 552 - 563
  • [2] TREATMENT OF HYPERCHOLESTEROLEMIA WITH THE HMG COA REDUCTASE INHIBITOR, SIMVASTATIN
    BERGER, GMB
    MARAIS, AD
    SEFTEL, HC
    BAKER, SG
    MENDELSOHN, D
    WELSH, NH
    JOFFE, BI
    CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 (02) : 219 - 227
  • [3] A 6-MONTH TRIAL OF SIMVASTATIN (HMG-COA REDUCTASE INHIBITOR) IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
    STEYN, K
    WEICH, HFH
    VERMAAK, WJH
    MARAIS, AD
    OMAR, MAK
    VANGELDER, AL
    FOURIE, J
    KOTZE, TJVW
    STANDER, I
    FIRTH, JC
    VANLATHEM, JM
    SOUTH AFRICAN MEDICAL JOURNAL, 1991, 79 (11): : 639 - 645
  • [4] FOCUS ON FLUVASTATIN - THE FIRST TOTALLY SYNTHETIC HMG-COA REDUCTASE INHIBITOR FOR TREATMENT OF HYPERCHOLESTEROLEMIA
    KELLICK, KA
    ELLIS, AK
    HOSPITAL FORMULARY, 1994, 29 (04): : 245 - 250
  • [5] Pitavastatin A New HMG-CoA Reductase Inhibitor for the Treatment of Hypercholesterolemia
    Ahmad, Haniyyah
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2010, 18 (05) : 264 - 267
  • [6] Simvastatin: In Vitro Metabolic Profiling of a Potent Competitive HMG-CoA Reductase Inhibitor
    Yin, Wencui
    Alwabli, Reem I.
    Attwa, Mohamed W.
    Rahman, A. F. M. Motiur
    Kadi, Adnan A.
    SEPARATIONS, 2022, 9 (12)
  • [7] Rosuvastatin - A new HMG-CoA reductase inhibitor for hypercholesterolemia
    Roach, AE
    Tsikouris, JP
    Haase, KK
    FORMULARY, 2002, 37 (04) : 179 - +
  • [8] Cerivastatin, a new potent HMG-CoA reductase inhibitor: Efficacy and tolerability in primary hypercholesterolemia
    Insull, W
    Stein, E
    Whalen, E
    Ripa, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 92192 - 92192
  • [9] UPDATE ON THE TREATMENT OF HYPERCHOLESTEROLEMIA, WITH A FOCUS ON HMG-COA REDUCTASE INHIBITORS AND COMBINATION REGIMENS
    GINSBERG, HN
    CLINICAL CARDIOLOGY, 1995, 18 (06) : 307 - 315
  • [10] The effect of the HMG-CoA reductase inhibitor, simvastatin, on the renal microcirculation
    Inman, SR
    Caprio, TW
    Drummond, EE
    Mueller, ME
    FASEB JOURNAL, 2005, 19 (05): : A1145 - A1146